1836
V. Boucard et al.
LETTER
The mixture was stirred at r.t. and the reaction was monitored by
TLC [Rf = 0.49 (HOAc/toluene 1/9)].
t-Bu
Si
NH2
COO(CH2)6CH3
O
t-Bu
O
The mixture was diluted in H2O (50 mL) and extracted with EtOAc
(3 × 50 mL). The combined organic layers were washed with brine
(50 mL), dried on Na2SO4 and evaporated. N-Fmoc-4-iodo-L-phe-
nylalanine heptyl ester 4 was obtained as a white solid (8.34 g,
86%), mp 54–55 °C. [a]D20 +22.8 (c 1.1, CHCl3). IR (KBr): 1690,
1726, 2924, 3321 cm–1. 1H NMR (250 MHz, CDCl3): d = 0.90 [t, 3
H, J = 6.4 Hz, CH3-(CH2)5], 1.30 [m, 8 H, (CH2)5], 1.60 [m, 2 H,
(CH2)5], 3.00 (m, 2 H, CH2-CH), 4.06–4.10 (m, 2 H, O-CH2 Fmoc),
4.13–4.22 (m, 1 H, H-9 Fmoc), 4.36–4.43 (m, 2 H, CH2-OCO), 4.5
(m, 1 H, CH2-CH), 5.30 (d, 1 H, NH, J = 7.8 Hz), 6.80 (d, 2 H, Har,
J = 8 Hz), 7.25–7.50 (m, 4 H, Har Fmoc), 7.55 (d, 2 H, J = 7 Hz, Har
Fmoc), 7.65 (d, 2 H, J = 8 Hz, Har), 7.70 (d, 2 H, J = 7.4 Hz, Har
Fmoc). 13C NMR (62.9 MHz, CDCl3): d = 14.0 [CH3-(CH2)5], 22.5,
25.7, 28.4, 28.8, 31.6 [(CH2)5], 37.8 (CH2-CH), 47.1 (CH C-9
Fmoc), 54.5 (CH2-CH), 65.8 (CH2-OCO), 66.8 (O-CH2 Fmoc),
92.5, 119.9, 127.7–127.0-125.0, 131.3, 135.4, 137.5, 141.3, 143.7
(Car), 155.4 (CON), 171.2 (COO). Anal. Calcd for C31H34NO4I: C,
60.89; H, 5.60; N, 2.29. Found: C, 60.94; H, 5.68; N, 2.31.
O
TIPSO
7
Figure 2
In conclusion, we have developed a convergent synthesis
of C-glycosylated aminoacids by carbon-carbon bond for-
mation according to a palladium catalyzed cross-coupling
procedure involving a stannyl or a zinc glucal and a phe-
nylalanine derivative. The functionalization of the cou-
pled product in order to obtain the C-glycosylated tyrosine
mime is under investigation in the laboratory.
Preparation of 4-Iodo-L-phenylalanine.
Preparation of (1,5-Anhydro-2-deoxy-4,6-tri-O-di-(tert-bu-
tyl)silanediyl-3-O-triisopropylsilyl-d-arabino-hex-1-enitolyl)-
N-(9-fluorenylmethoxycarbonyl)-l-phenylalanine Heptyl Ester
(5).
In a solution of L-phenylalanine (10 g, 60 mmol) dissolved in acetic
acid (55 mL) and concentrated sulfuric acid (7 mL), iodine (6.15 g,
24 mmol) and sodium iodate (2.54 g, 6.29 mmol) were added. The
mixture was stirred vigorously and heated at 70 °C during 21 h.
Then NaIO4 was introduced (2 × 0.25 g). At the end of the reaction,
the solution became orange. Acetic acid was removed in vacuo and
the crude was diluted in H2O (100 mL). The aqueous layer was ex-
tracted with Et2O (2 × 25 mL) and CH2CL2 (2 × 25 mL). The com-
bined organic layers were decolored by norite (1.25 g), then
filtrated. pH was increased to 5 with aq concd NaOH. The precipi-
tate was filtered, washed with H2O (200 mL) and EtOH (75 mL)
yielding 4-iodophenylalanine as a white solid, 9.4 g (53%), mp
255–265 °C, used in the next step without purification.
Tin-mediated Procedure: In a Schlenk tube, t-BuLi (1.7 M, 1.6
mL) was slowly added to a solution of the protected glucal 2 (300
mg, 0.68 mmol) in freshly distilled THF (2.7 mL) stirred at –78 °C.
The solution was then stirred during 30 min at 0 °C. Tributyltin
chloride (0.46 mL, 1.7 mmol) was added at –78 °C and the mixture
was stirred for 1 h at 0 °C. After hydrolysis at 0 °C, the aqueous
phase was extracted with Et2O. Combined organic extracts were
washed with H2O and brine, then dried over MgSO4. Purification by
flash chromatography (pure hexane) afforded the product 2¢a (260
mg, 52%). This compound was dissolved in anhydrous toluene (4
mL) and iodophenylalanine 4 (324 mg, 0.53 mmol) was added. This
mixture was then transferred by cannula into a solution of Pd(PPh3)4
(34 mg, 0.04 mmol) and CuI (13 mg, 0.07 mmol) in toluene (4 mL)
and heated at 90 °C for 16 h. After cooling at r.t. the solvent was re-
moved and the residue was purified by flash chromatography (pure
hexane) affording a mixture of 5 (164 mg, 50%) and 6 (130 mg,
42%).
Preparation of 4-Iodo-L-phenylalanine Heptyl Ester p-Toluene-
sulfonate (3).
A solution of 4-iodophenylalanine (7.5 g, 25.7 mmol) and p-tolue-
nesulfonic acid (7.3 g, 38.5 mmol) in benzene (125 mL) and hep-
tanol (18.7 mL) was refluxed until H2O was separated. The solution
was concentrated in vacuo and the product was crystallized in Et2O.
The filtration furnished the compound as a white solid, 7.817 g
Zinc-mediated Procedure: In a Schlenk tube, t-BuLi (1.7 M, 540
mL) was slowly added to a solution of the protected glucal 2 (216
mg, 0.49 mmol) in freshly distilled THF (2.7 mL) stirred at –78 °C.
The solution was then stirred during 30 min at r.t. In another
Schlenk tube, ZnCl2 (164 mg, 1.2 mmol) was heated under reduced
pressure during 15 min. Then, THF (2.7 mL) was added. This sec-
ond solution was transferred into the first one and was stirred 1 h at
r.t. In another Schlenk tube, a solution of the catalyst was prepared
by dissolving Pd2(dba)3·CHCl3 (14 mg, 0.014 mmol), tri-(o-
tolyl)phosphine (30 mg, 0.1 mmol) in THF (2.3 mL). A solution of
iodophenylalanine 4 (160 mg, 0.26 mmol) in THF (2.3 mL) was
slowly added at r.t. Finally, the solution of the organozinc com-
pound was transferred by cannula into the solution containing the
catalyst and the aryl iodide. The mixture was stirred during 3 h. The
mixture was diluted in brine (6 mL) and extracted with EtOAc
(3 × 10 mL). The combined organic layers were washed with brine
(6 mL), dried on Na2SO4 and evaporated under reduced pressure.
Purification by flash chromatography (cyclohexane–EtOAc 98/2)
afforded the product 5 (166 mg, 69%) mp 58–62 °C. [a]D20 +5.6 (c
1, CHCl3). Rf = 0.41 (cyclohexane/EtOAc 9/1). IR (KBr): 1732,
20
(53%), mp 118–121 °C. [a]D +19.1 (c 1, CHCl3). Rf = 0.92
(CH2Cl2/MeOH 8/2), ninhydrine. IR (KBr): 1744, 3015, 3403 cm–
1. 1H NMR (250 MHz, CDCl3): d = 0.75 [t, 3 H, CH3-(CH2)5], 1.01–
1.27 [m, 10 H, (CH2)5], 2.3 (s, 3 H, CH3-Ph), 2.90–3.00 (m, 1 H,
CH2-CH), 3.10 (m, 1 H, CH2-CH), 3.80 (m, 2 H, CH2-O), 4.20 (s, 1
H, CH2-CH), 6.80 (d, 2 H, Har, J = 10 Hz), 7.10 (d, 2 H, Har J = 7.5
Hz), 7.40 (d, 2 H, Har, J = 7.5 Hz), 7.60 (d, 2 H, Har, J = 10 Hz),
8.20 (brs, 3 H, NH3). 13C NMR (62.9 MHz, CDCl3): d = 14 [CH3-
(CH2)5], 21.3 (CH3-Ph), 22.6, 25.5, 28.0, 28.8, 31.6 [(CH2)5], 35.7
(CH2-CH). 53.8 (CH2-CH), 66.3 (CH2-O), 92.0, 126.0, 128.9,
131.2, 134.1, 136.9, 137.4, 137.5, 141.2 (Car), 174.8 (CO).
Preparation of N-Fmoc-4-iodo-L-phenylalanine Heptyl Ester
(4).
A solution of 4-iodo-L-phenylalanine heptyl ester, TsOH 3 (7.8 g,
13.5 mmol) in CH2Cl2 (100 mL) was washed with 10% NaHCO3
(2 × 100 mL). The organic layer was dried on Na2SO4. After filtra-
tion and evaporation under reduced pressure, 4-iodo-L-phenylala-
nine heptyl ester was obtained as a colorless syrup (6.33 g, 100%).
Rf = 0.85 (CH2Cl2/MeOH 8/2).
1
2933, 3356 cm–1. H NMR (250 MHz, CDCl3): d = 0.80–1.40 [m,
4-Iodo-L-phenylalanine heptyl ester (6.16 g, 16 mmol) was added in
a 10% Na2CO3 solution cooled at 0 °C. The mixture was stirred dur-
ing 15 min and a solution of 9-fluorenylmethoxycarbonyl succinim-
ide (4.512 g, 13.4 mmol) in dioxane (37.5 mL) was added dropwise.
52 H, CH3-(CH2)5, (CH3)3C, (CH3)2CH)], 3.10 (m, 2 H, CH2-CH),
4.00–4.18 (7 H, m, H4, H5, H6,6¢, O-CH2 Fmoc, H-9 Fmoc), 4.20–
4.30 [m, 1 H, O-CHH-(CH2)4], 4.27–4.40 [m, 1 H, O-CHH-(CH2)4],
4.60 (dd, 1 H, H3, J = 2.3 Hz, J = 6.5 Hz), 4.60–4.80 (m, 1 H, CH2-
Synlett 2003, No. 12, 1834–1837 © Thieme Stuttgart · New York